CHEMOTHERAPY

Abbr. CHEMOTHERAPY ·SWITZERLAND ·Frequency Bimonthly ·Avg. articles/yr 0 articles

1.7

Latest IF

0.00%

Self-citation

较易

Submission difficulty

较慢,6 - 12周

Review cycle

About Journal

Chemotherapy杂志的ISSN号是0009-3157，由瑞士的Karger出版社出版，出版周期为双月刊，出版地为瑞士巴塞尔。该杂志的影响因子根据年份有所不同，最新数据需查询官方来源，目前为非开放获取（非OA）期刊，被SCI收录，中科院分区情况需参考最新分区表。杂志主要关注化疗领域的研究，包括抗癌药物、抗菌药物、抗寄生虫药物等的药理学、毒理学及临床应用，发文特点为涵盖基础与临床研究，注重药物疗效与安全性的评估。杂志质量较高，因其专业性在化疗领域有一定影响力，但需注意其影响因子波动可能带来的投稿风险，建议投稿前查阅最新评价数据以确认其学术地位。

IF Trend

Recent Articles

Therapeutic Drug Monitoring of Linezolid in Real-World Clinical Practice: Determinants of Exposure, Dose Optimization, and Hematological Toxicity 2026-07-09

Beyond Conventional Monoclonals: Novel Antibody Formats and Derivatives as the Next Frontier in Cancer Therapy 2026-06-29

Pseudoprogression of a Head and Neck Cutaneous Squamous Cell Carcinoma Treated with Anti-PD-1 Immunotherapy: A Case Report and Review of the Literature 2026-06-05

Clinical Feasibility of Platinum-Based Chemotherapy Followed by Avelumab Maintenance after Enfortumab Vedotin plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Case Series 2026-05-21

Efficacy and Safety Study of Different Doses of Linezolid in Combination with Bedaquiline in the Treatment of Drug-Resistant Pulmonary Tuberculosis 2026-04-08

Can Model-Informed Precision Dosing of Beta-Lactams in Critical Care Improve Clinical Outcomes? 2026-02-03

Expression of Concern 2026-01-21

Drug-Drug Interaction between Toosendanin and Tamoxifen and Its Potential Mechanism 2025-12-23

Acknowledgement to Reviewers 2025-11-10

Novel Insights into Epiploic Appendagitis in a Breast Cancer Patient on Abemaciclib: A Case Report 2025-09-17